Our organization is conducting a study for patients with primary immunodeficiency and end-stage lung disease. Patients with immunodeficiencies often develop lung complications or infections that make them ineligible for life-saving immunotherapy.
In this study, we are performing a lung transplant as well as a bone marrow transplant from the same donor.
The bone marrow transplant will provide stem cells that should generate a new immune system in the patient, which we expect will resolve the patient’s immunodeficiency and prevent organ rejection.
Initiated by the UPMC Immune Transplant and Therapy Center.